Research suggests that Vidari Kanda (Pueraria tuberosa) has a long-standing classification in Ayurvedic medicine as a Rasayana herb — a traditional category associated with rejuvenation and longevity — and the available published literature consistently supports this traditional framing at a preliminary level. Studies indicate that the plant's tuber contains bioactive isoflavones, particularly puerarin, genistein, and daidzein, which are associated with antioxidant, immunomodulatory, and neuroprotective effects in laboratory and animal models, all of which are considered mechanistically relevant to aging processes. The current body of evidence consists primarily of reviews and secondary analyses rather than controlled clinical trials or randomized studies in humans, meaning the observed effects have not yet been rigorously tested in people under experimental conditions. Reviewers in this area consistently note that while the pharmacological rationale is plausible and the traditional use is well-documented, human clinical research is needed before firm conclusions can be drawn about its efficacy as an anti-aging intervention.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Pueraria tuberosa: a review on its phytochemical and therapeutic potential. | Review | 2014 | Supports | 90 |
| Pueraria tuberosa: A Review on Traditional Uses, Pharmacology, and Phytochemi... | Review | 2020 | Supports | 75 |
| Antioxidant and Antiapoptotic effect of aqueous extract of Pueraria tuberosa ... | Other | 2018 | Supports | 72 |
| A fraction of Pueraria tuberosa extract, rich in antioxidant compounds, allev... | Other | 2021 | Supports | 65 |